N. A. Aziz

Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England

A. Presanis, D. De Angelis, J. Bridgen, 2022, Nature Communications.

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

S. Bhatt, S. Flaxman, W. Hinsley, 2022, The Lancet.

The impact of COVID‐19 on residents of long‐term care facilities with learning disabilities and/or autism

T. Lamagni, J. Flannagan, G. Dabrera, 2023, Influenza and other respiratory viruses.

Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England

J. L. Bernal, R. Hope, G. Dabrera, 2023, Journal of Infection.

Vaccine effectiveness against hospitalisation and comparative odds of hospital admission and severe outcomes with BQ.1, CH.1.1. and XBB.1.5 in England.

J. L. Bernal, Katie Harman, R. Hope, 2023, medRxiv.

Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75 and BQ.1 compared to BA.5 in England

J. L. Bernal, R. Hope, G. Dabrera, 2023, medRxiv.

Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020

A. Charlett, D. Chudasama, K. Twohig, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.